PubRank

Yehuda Ringel

Author PubWeight™ 49.34‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med 2011 10.03
2 Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology 2012 7.15
3 The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol 2006 2.93
4 Randomized controlled trial shows biofeedback to be superior to pelvic floor exercises for fecal incontinence. Dis Colon Rectum 2009 2.24
5 Digestive and liver diseases statistics, 2004. Gastroenterology 2004 2.14
6 Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study. J Clin Gastroenterol 2011 1.88
7 Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe 2012 1.81
8 Randomized, controlled trial shows biofeedback to be superior to alternative treatments for patients with pelvic floor dyssynergia-type constipation. Dis Colon Rectum 2007 1.69
9 Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2011 1.49
10 Characterization of the fecal microbiota using high-throughput sequencing reveals a stable microbial community during storage. PLoS One 2012 1.41
11 Increased colonic pain sensitivity in irritable bowel syndrome is the result of an increased tendency to report pain rather than increased neurosensory sensitivity. Gut 2007 1.39
12 Alterations of brain activity associated with resolution of emotional distress and pain in a case of severe irritable bowel syndrome. Gastroenterology 2003 1.23
13 Recommendations for probiotic use-2011 update. J Clin Gastroenterol 2011 1.19
14 Prebiotics and the health benefits of fiber: current regulatory status, future research, and goals. J Nutr 2012 1.17
15 Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Gut Pathog 2010 1.17
16 The intestinal microbiome, probiotics and prebiotics in neurogastroenterology. Gut Microbes 2012 1.12
17 Intestinal microbiota in healthy U.S. young children and adults--a high throughput microarray analysis. PLoS One 2013 1.04
18 Anti-enteric neuronal antibodies and the irritable bowel syndrome. J Neurogastroenterol Motil 2012 0.98
19 Recommendations for Probiotic Use-2015 Update: Proceedings and Consensus Opinion. J Clin Gastroenterol 2015 0.89
20 Luminal cysteine-proteases degrade colonic tight junction structure and are responsible for abdominal pain in constipation-predominant IBS. Am J Gastroenterol 2013 0.86
21 Low-dose naltreoxone for the treatment of irritable bowel syndrome: a pilot study. Dig Dis Sci 2006 0.85
22 Fecal protease activity is associated with compositional alterations in the intestinal microbiota. PLoS One 2013 0.82
23 Selected topics in probiotics and prebiotics: meeting report for the 2004 international scientific association for probiotics and prebiotics. Curr Issues Intest Microbiol 2005 0.80
24 High-sensitive C-Reactive Protein as a Marker for Inflammation in Irritable Bowel Syndrome. J Clin Gastroenterol 2016 0.78
25 Lubiprostone: easing the strain of constipation? Gastroenterology 2008 0.78
26 Treatment of functional diarrhea. Curr Treat Options Gastroenterol 2006 0.78
27 Is there a role for octreotide, a somatostatin analog, in the treatment of functional GI disorders? Gastroenterology 2004 0.75
28 Functional chest pain of presumed esophageal origin. Arch Intern Med 2002 0.75
29 Probiotics in irritable bowel syndrome: has the time arrived? Gastroenterology 2007 0.75
30 Anti-platelet therapy and recurrent ulcers: Rethinking rebleeding. Gastroenterology 2005 0.75
31 Colectomy for colonic inertia: successful relief of constipation is not enough. Gastroenterology 2006 0.75
32 Colon ischemia--need to unravel its predisposition. Gastroenterology 2005 0.75